PLATFORM LOGINS
NaviNet
Eviti Connect
• Oncology
• Autoimmune Diseases
Eviti Advisor
|
CONTACT
Request a Demo
Search
Submit
Payers
Payers
Overview
Eviti Connect
Evidence-based treatment validation platform to enable cost-effective oncology and autoimmune disease care
NaviNet Open
Payer-provider collaboration platform for sharing vital administrative and clinical information in near real-time
Population Health Management
Platform to bridge disparate patient data and facilitate efficient care coordination
Providers
Providers
Overview
Eviti Advisor
Oncology clinical decision support to empower confident treatment decisions
NaviNet
Fast, intuitive provider access to health plans with a single login
Network Operations
Network Operations
Overview
Healthcare
IT network monitoring and management solution for healthcare
Enterprises
IT network monitoring and management solutions
Resources
Blog
Press Releases
Media Coverage
Events
Clinical Guidelines
HUM Criteria
Digital Library
Brochures
Case Studies
Data Sheets
Fact Sheets
Infographics
Webinars
White Papers
Videos
About Us
Our Team
Board of Directors
Investors
Careers
Our Core Values
All Current Openings
Diversity & Inclusion
Benefits
Search
Submit
Home
Payers
Eviti Connect
NaviNet Open
Population Health Management
Providers
Eviti Advisor
NaviNet
Network Operations
Healthcare
Enterprises
Resources
Blog
Press Releases
Media Coverage
Events
Clinical Guidelines
HUM Criteria
Digital Library
Brochures
Case Studies
Data Sheets
Fact Sheets
Infographics
Webinars
White Papers
Videos
About Us
Our Team
Board of Directors
Investors
Careers
Our Core Values
All Current Openings
Diversity & Inclusion
Benefits
Home Page
Stock Information
Stock Price
News & Events
Press Releases
Events & Presentations
Filings & Financials
SEC Filings
Financial Document Library
Corporate Governance
Governance Highlights
Board of Directors
Management Team
Committee Composition
Board Diversity Matrix
Shareholder Resources
Email Alerts
Information Request
Investor FAQ
Contact Us
Fact Sheet
Press Releases
All
2023
2022
2021
2020
2019
2018
2017
2016
Search Keyword
December 19, 2016
NantHealth to Present at the 35th Annual J.P. Morgan Healthcare Conference on January 9
Read More
December 16, 2016
NantHealth, Inc. Announces Pricing of $100 Million of 5.50% Convertible Notes
Read More
December 15, 2016
NantHealth, Inc. Announces Proposed $100 Million Convertible Notes Offering
Read More
December 13, 2016
NantHealth Expands Adoption of GPS CancerTM with New Florida Genomics Lab License and Successful Adoption by Florida Community Oncologists
Read More
December 13, 2016
NantHealth Added to Nasdaq Biotech Index
Read More
December 8, 2016
NantHealth, NantKwest and NantOmics Announce Availability of GPS Cancer™ and Phase I – III QUILT Trials Through the U.S. National Institutes of Health’s ClinicalTrials.gov
Read More
December 7, 2016
NantHealth And TransMed Systems Partner to Enable and Inform Community Oncologists of the Most Effective Tools and Technologies for Personalized Cancer Treatments Using GPS Cancer™
Read More
December 6, 2016
NantHealth Announces Exclusive Reseller Agreement for GPS Cancer™ with Oncotest-Teva in Israel
Read More
December 5, 2016
NantHealth Continues Global Expansion Of GPS Cancer™ By Bringing Advanced Molecular Profiling to Patients in the Middle East Through Partnership with Lunatus
Read More
November 7, 2016
NantHealth Reports 76% Increase in Total Q3 Net Revenue 2016 vs 2015, Gross Profit Triples
Read More
Looking for older Press Releases? Check out the full archive here.
«
1
2
...
13
14
15
16
17
»